• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J.Infect.Dis. Whole exome sequencing reveals mutations in hemophagocytic lymphohistiocytosis and macrophage activation syndrome linked genes in fatal

tetano

Editor, Senior Moderator
  1. J Infect Dis. (2015) doi: 10.1093/infdis/jiv550 First published online: November 23, 2015

[h=1]Whole exome sequencing reveals mutations in hemophagocytic lymphohistiocytosis and macrophage activation syndrome linked genes in fatal cases of H1N1 influenza[/h]
+ Author Affiliations
  • [SUP]1[/SUP]Division of Pediatric Rheumatology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH
  • [SUP]2[/SUP]Division of Pediatric Rheumatology, Children's Hospital of Alabama/University of Alabama at Birmingham, Birmingham, AL
  • [SUP]3[/SUP]Division of Human Genetics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH
  • [SUP]4[/SUP]Department of Pathology, University of Michigan Medical School, Ann Arbor, MI
  • [SUP]5[/SUP]Department of Surgery, University of Michigan Medical School, Ann Arbor, MI
  • [SUP]6[/SUP]Department of Dermatology, University of Michigan Medical School, Ann Arbor, MI
  • [SUP]7[/SUP]Michigan Center for Translational Pathology, University of Michigan Medical School, Ann Arbor, MI
  • Address for Correspondence: Randy Q. Cron MD, PhD, Division of Pediatric Rheumatology, Children's Hospital of Alabama/University of Alabama at Birmingham, Children's Park Place, Ste. 210, 1601 4[SUP]th[/SUP] Avenue South, Birmingham, AL 35233, P: (205) 996-9191, F: (205) 996-9545, rcron@peds.uab.edu Or Alexei A. Grom MD, Division of Pediatric Rheumatology, Cincinnati Children's Hospital Medical Center, 3333 Burnet Avenue, MLC 4010, Cincinnati, OH 45229, P: (513) 636-3339, F: (513) 636-5568, alexi.grom@cchmc.org

[h=2]Abstract[/h] Background.  Severe H1N1 influenza can be lethal in otherwise healthy individuals, and have features of secondary hemophagocytic lymphohistiocytosis (HLH). HLH is associated with mutations in lymphocyte cytolytic pathway genes, which have not been previously explored in H1N1 influenza.
Methods. Sixteen cases of fatal H1N1 infection, 81% with histopathologic hemophagocytosis, were identified and analyzed for clinical and laboratory features of HLH using modified HLH-2004 and macrophage activation syndrome (MAS) criteria. Fourteen specimens were subject to whole exome sequencing. Sequence alignment and variant filtering detected HLH gene mutations and potential disease-causing variants. Cytolytic function of the PRF1 p.A91V mutation was tested in lentiviral-transduced NK-92 natural killer (NK) cells.
Results. Despite several lacking variables, H1N1 cases met 44% and 81% of modified HLH-2004 and MAS criteria, respectively. Five subjects (36%) carried one of 3 heterozygous LYST mutations, 2 of whom also possessed the p.A91V PRF1 mutation, which was shown to decrease NK cell cytolytic function. Several patients also carried rare variants in other genes previously observed in MAS.
Conclusions.  This cohort of fatal H1N1 influenza infections confirms the presence of hemophagocytosis and HLH pathology. Moreover, the high percentage of HLH gene mutations suggests they are risk factors for mortality among H1N1 influenza infection.

http://jid.oxfordjournals.org/content/early/2015/11/23/infdis.jiv550
 
Back
Top Bottom